Skip to main content

SYNERON MEDICAL LTD Value Stock - Dividend - Research Selection

Syneron medical ltd

ISIN: IL0010909351 , WKN: A0B7YM

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Syneron Medical Ltd. designs, develops and sells aesthetic medical devices based on its various technologies, including its electro-optical synergy (ELOS) technology, which utilizes the synergy between electrical energy, including radio frequency (RF) energy, and optical energy aesthetic medical treatments. The company's products, which are sold primarily to physicians and other practitioners, target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of Veins of the leg, treatment to temporarily reduce the appearance of cellulite and thigh circumference and laser assisted lipolysis. On February 13, 2012, the company acquired Ultrashape Ltd. On March 14, 2012, Syneron acquired substantially all assets of TransPharma Medical Ltd.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,